GSK-1322322
N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
Cat. No.1152107259
CAS1152107-25-9
Purity99.61%
| Catalog No. | 1152107259 |
|---|---|
| CAS Number | 1152107-25-9 |
| IUPAC Name | N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide |
| Purity | 99.61% |
| SMILES | C1(NNC(=O)[C@H](CC2CCCC2)CN(C=O)O)C(F)=C(N2C[C@@]3([H])COCCN3CC2)N=C(C)N=1 |
Certificate of Analysis (COA)
Batch-specific analytical results confirming purity, identity, and quality.
Safety Data Sheet (SDS)
GHS-compliant safety information including hazards, handling, and disposal.
This product is not classified as a hazardous material under standard shipping regulations.
For complete safety information, always refer to the product's Safety Data Sheet.